Karmen Javanizadeh, PA

Karmen Javanizadeh practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Karmen Javanizadeh's NPI, 1255403770, was assigned on November 14, 2006. Karmen Javanizadeh holds California license PA15603.

Karmen Javanizadeh's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Karmen Javanizadeh's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Karmen Javanizadeh to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Karmen Javanizadeh practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Karmen Javanizadeh's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Karmen Javanizadeh is licensed in California.

CMS data shows 157 Medicare services from Karmen Javanizadeh across 2 procedure codes in 2024, all of them office visits, for 159 Medicare patients. Medicare paid $15,682 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 159 Medicare patients who saw Karmen Javanizadeh in 2024. The largest group is 65 to 74, with 88 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Karmen Javanizadeh's median patient age at 71, with 39% women.

In 2024, Karmen Javanizadeh wrote 114 Medicare Part D claims for 57 patients. 92% of them were for generic drugs. CMS names the drug for 44 of them, across 3 drugs with 11 or more claims each, at $1,235 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Karmen Javanizadeh for performance year 2024, reported as part of a group. Karmen Javanizadeh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Karmen Javanizadeh as offering telehealth.

CMS Open Payments shows 1 general payment to Karmen Javanizadeh from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Biogen, Inc. paid the most, $123.